Category Archives: "COVID-19"

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab [...]
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry
Key Points Question How do patients with multiple sclerosis (MS) who have COVID-19 fare and are there patient and disease [...]
Guidance for the Use of Disease Modifying Therapies During the COVID-19 pandemic
People with MS have asked for guidance on the use of Disease Modifying Therapies (DMTs) during the COVID-19 pandemic. There are numerous [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM